D-0423-2018 Class II Terminated
FDA drug recall D-0423-2018 was initiated by PharMEDium Services, LLC on Feb 5, 2018 and is designated Class II. Reason for recall: Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin. The recall status is terminated (terminated Apr 24, 2018). Affected quantity: 21 Cassettes.
Recall Details
- Product Type
- Drugs
- Report Date
- Feb 21, 2018
- Initiation Date
- Feb 5, 2018
- Termination Date
- Apr 24, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 21 Cassettes
Product Description
0.2% Ropivacaine HCI (Preservative Free) in 0.9 Sodium Chloride, Epidural, 250 mL Yellow Cassette, Rx only, PharMEDium Serivces, LLC
Reason for Recall
Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.
Distribution Pattern
Product was distributed to SC, FL, NY, NY,WA
Code Information
Lot #: 180030029D, Exp 2/18/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0423-2018
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026